Manage stand orders
Select Option
aparito Ltd.
Unit 11 Gwenfro Technology Park Croesnew,
LL13 7YP
Wrexham
United Kingdom of Great Britain and Northern Ireland
United Kingdom of Great Britain and Northern Ireland
This company is co-exhibitor of
Wales Government
Contact
Our range of products
Product categories
- 06 Information and communication technology
- 06.02 mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI)
mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI)
- 06 Information and communication technology
- 06.03 Wearable technologies, smart textiles
Wearable technologies, smart textiles
- 06 Information and communication technology
- 06.04 eHealth, telemedicine / telematics / telemetry
eHealth, telemedicine / telematics / telemetry
Company news
Date
Topic
Download
Nov 16, 2020
Aparito's timely response to the COVID pandemic.
APARITO’S TIMELY RESPONSE TO COVID-19 FOR AT RISK ONCOLOGY PATIENTS
Aparito’s technological offerings are highly configurable, hence the ability to respond quickly to the current
pandemic. Five weeks and two days after the COVID-19 pandemic was announced by the WHO, Aparito had
successfully secured the Techforce19 NHSX contract which allowed for the deployment of the remote patient monitoring technology. By the 26th of April, the first oncology patient at Betsi Cadwaladr University Health Board (BCUHB) was onboarded onto the system.
The configuration deployed within Aparito’s platform allows for the remote collating of patient-specific metrics
on a longitudinal basis, irrespective of the disease. The metrics measured are both qualitative and quantitative,
and as a result provide a well rounded and in-depth portrayal of each patient’s experience. The addition of
a clinician portal and dashboard also allows clinicians and all individuals invested in the care of a patient to
monitor metrics remotely, and in real-time.
COVID-specific configurations were made for this deployment, which was in keeping with the current scientific
evidence available. This allowed for the development of a “Symptoms Checker” comprising identified COVID-19
symptoms, which was accessed through the mobile application with an alert and notification to patients to
complete. Additional metrics were aggregated by the Garmin wearable device which was selected for this
deployment because of its availability, cost and easy to use approach which appeals to patients. Data capture is
made easy as Aparito is a Garmin Partner and benefits from the SDK Companion allowing us access to raw data
such as:
-Oxygen saturation within blood (SPO2 [spot check in the day time and and continuous while asleep])
-Heart rate (per minute)
-Proportion of light and deep sleep
-Number of steps taken
-The type of motion carried out and the intensity
The following three parameters were reported manually by patients through the mobile application:
-Respiratory rate
-Temperature
-Blood pressure
Aparito’s technological offerings are highly configurable, hence the ability to respond quickly to the current
pandemic. Five weeks and two days after the COVID-19 pandemic was announced by the WHO, Aparito had
successfully secured the Techforce19 NHSX contract which allowed for the deployment of the remote patient monitoring technology. By the 26th of April, the first oncology patient at Betsi Cadwaladr University Health Board (BCUHB) was onboarded onto the system.
The configuration deployed within Aparito’s platform allows for the remote collating of patient-specific metrics
on a longitudinal basis, irrespective of the disease. The metrics measured are both qualitative and quantitative,
and as a result provide a well rounded and in-depth portrayal of each patient’s experience. The addition of
a clinician portal and dashboard also allows clinicians and all individuals invested in the care of a patient to
monitor metrics remotely, and in real-time.
COVID-specific configurations were made for this deployment, which was in keeping with the current scientific
evidence available. This allowed for the development of a “Symptoms Checker” comprising identified COVID-19
symptoms, which was accessed through the mobile application with an alert and notification to patients to
complete. Additional metrics were aggregated by the Garmin wearable device which was selected for this
deployment because of its availability, cost and easy to use approach which appeals to patients. Data capture is
made easy as Aparito is a Garmin Partner and benefits from the SDK Companion allowing us access to raw data
such as:
-Oxygen saturation within blood (SPO2 [spot check in the day time and and continuous while asleep])
-Heart rate (per minute)
-Proportion of light and deep sleep
-Number of steps taken
-The type of motion carried out and the intensity
The following three parameters were reported manually by patients through the mobile application:
-Respiratory rate
-Temperature
-Blood pressure
About us
Company details
Aparito is recognised as a leader in the med-tech space and was awarded "Digital Health Innovators of the Year" and "Best Remote Patient Monitoring Solution" in the Global Healthcare and Pharmacutical Awards 2020.
Aparito is a med-tech company specialising in capturing patient generated data and digital endpoints remotely, with a specific expertise in decentralised/ hybrid studies. As a leading provider of mHealth and remote patient monitoring technology with specialist regulatory and clinical expertise, with our technology it is possible to capture Real-World Patient Data through a variety of sources. These include eQuestionnaires, videos, voice, secure messaging, pictures and wearable device integration.
Aparito is uniquely positioned to rapidly provide a wide-ranging technology solution for the collection of eCOA and ePROs and general data collection. With the ability to capture and store digital endpoints in our Atom5 ™ platform.
We are Cyber Essentials compliant, annually penetration tested by CREST certified testers, acredited to ISO27001 and ISO13485 and have been awarded the ePrivacy seel.
Aparito is a med-tech company specialising in capturing patient generated data and digital endpoints remotely, with a specific expertise in decentralised/ hybrid studies. As a leading provider of mHealth and remote patient monitoring technology with specialist regulatory and clinical expertise, with our technology it is possible to capture Real-World Patient Data through a variety of sources. These include eQuestionnaires, videos, voice, secure messaging, pictures and wearable device integration.
Aparito is uniquely positioned to rapidly provide a wide-ranging technology solution for the collection of eCOA and ePROs and general data collection. With the ability to capture and store digital endpoints in our Atom5 ™ platform.
We are Cyber Essentials compliant, annually penetration tested by CREST certified testers, acredited to ISO27001 and ISO13485 and have been awarded the ePrivacy seel.